XML 31 R16.htm IDEA: XBRL DOCUMENT  v2.3.0.11
11. Stock Based Compensation
6 Months Ended
Jun. 30, 2011
Stockholders' Equity Note Disclosure [Text Block]
11. Stock Based Compensation

Stock Option Plan

The Company maintains two equity plans: the 2005 Equity Incentive Plan (the “2005 Plan”) and the 2010 Stock Incentive Plan (the “2010 Plan”).

The 2005 Plan, which was approved by the Company’s stockholders in August 2006, permits the Company to grant shares of common stock and options to purchase shares of common stock to the Company’s employees for up to 5 million shares of common stock.  The Company believes that such awards better align the interests of its employees with those of its stockholders.  Option awards are generally granted with an exercise price that equals the market price of the Company's stock at the date of grant; these option awards generally vest based on 3 years of continuous service and have 10-year contractual terms.  On November 8, 2007, the Board of Directors approved an amendment to the 2005 Plan to increase the number of shares of common stock available for grant to 113,333 shares. On December 11, 2008, the Board of Directors approved an additional amendment to the 2005 Plan to increase the number of shares of common stock available for grant to 206,667 shares.  At June 30, 2011 there were 127,256 options outstanding under the 2005 plan.  The Board of Directors has indicated that it does not intend to make any further option grants under the 2005 Plan.

The 2010 Plan, which was approved by the Company’s stockholders in July 2010, permits the Company to grant options to purchase, and other stock-based awards covering, in the aggregate 1,189,198 shares of the Company’s common stock to the Company’s employees, directors or consultants.   The Company believes that such awards will aid in recruiting and retaining key employees, directors or consultants and to motivate such employees, directors or consultants to exert their best effort on behalf of the Company.  Option awards are granted in four Tranches with Tranche 1 shares having an option price of $3.00 per share and Tranches 2, 3, and 4 having an option price of $5.778 per share.  Tranche 1 option awards vest fifty percent (50%) of the awarded shares upon Hale receiving cash proceeds in return on its Invested Capital in the Company and its subsidiaries which cash proceeds equal no less than one times its Invested Capital plus a four percent (4%) annual return on such Invested Capital, compounded annually (the “Tranche 1 Return”).  Notwithstanding the foregoing and the failure of Hale to have achieved the Tranche I Return, Tranche 1 shares shall vest with respect to ten percent (10%) of such Tranche 1 shares on each of the first, second, and third anniversaries of the Effective Date, irrespective of whether such Tranche 1 shares were issued as of such dates subject to the Participant’s continued employment in good standing with the Company on each such anniversary.   Tranche 2 option awards vest sixteen and sixty-fifth one hundredths percent (16.65%) upon Hale receiving cash proceeds in return on its Invested Capital in the Company and its subsidiaries which cash proceeds equal no less than two times its Invested Capital plus four percent (4%) annual return on such Invested Capital, compounded annually and subject to the Participant’s continued employment in good standing with the Company on the Tranche 2 vesting date.  Tranche 3 option awards vest sixteen and sixty-fifth one hundredths percent (16.65%) upon Hale receiving cash proceeds in return on its Invested Capital in the Company and its subsidiaries which cash proceeds equal no less than three times its Invested Capital plus four percent (4%) annual return on such Invested Capital, compounded annually and subject to the Participant’s continued employment in good standing with the Company on the Tranche 3 vesting date.  Tranche 4 option awards vest sixteen and seventieth one hundredths percent (16.67%) upon Hale receiving cash proceeds in return on its Invested Capital in the Company and its subsidiaries which cash proceeds equal no less than four times its Invested Capital plus four percent (4%) annual return on such Invested Capital, compounded annually and subject to the Participant’s continued employment in good standing with the Company on the Tranche 4 vesting date.  Option under the 2010 Plan shall be exercisable at such time and upon such terms and conditions as may be determined by the Committee, but in no event shall an Option be exercisable more than ten years after the date it is granted.

An amendment to the 2010 Plan (the “2010 Plan Amendment”) was approved by the Company’s stockholders and became effective in May 2011.   The 2010 Plan Amendment was adopted in connection with the terms of the Hale Securities Purchase Agreement dated June 30, 2010.  Pursuant to Section 1(e) of the Hale Securities Purchase Agreement the Company agreed to grant shares of common stock to Hale, in the event that the Company received a notice  that it is obligated to pay certain specified contingent liabilities within two years of the closing (a “Contingent Share Issuance”).  The Company received such notice in April 2011, and in accordance with the terms of the Hale Securities Purchase Agreement, the Company issued an aggregate of 225,576 shares of common stock to Hale.  The Hale Securities Purchase Agreement provides that in the event of a Contingent Share Issuance a proportionate adjustment would be made to the number of shares of our common stock reserved under the 2010 Plan.  Based on the Contingent Share Issuance, the Company’s board of directors approved an increase in the number of shares of common stock subject to the 2010 Plan from 1,189,198 to 1,232,121 shares.  In addition the 2010 Plan Amendment provides that the maximum aggregate number of shares available for issuance under the Plan will increase automatically by one share for every four shares issued in any future Contingent Share Issuance up to a maximum of 1,493,333 shares.  

A summary of option activity under the 2005 Plan and 2010 Plan as of June 30, 2011, and changes during the three months then ended is presented below:

   
Shares
   
Weighted-Average Exercise Price
 
Outstanding at December 31, 2010
   
954,979
   
$
6.00
 
Granted
   
192, 330
     
4.40
 
Exercised
   
     
 
Forfeited or expired
   
(118,332
)
   
4.40
 
Outstanding at June 30, 2011
   
1,028,977
   
$
5.66
 

The options outstanding and currently exercisable by exercise price at June 30, 2011 are as follows:

   
Stock options outstanding
 
Stock Options Exercisable
Range of Exercise Prices
 
Number Outstanding
 
Weighted-Average Remaining Contractual Term (Years)
 
Weighted-Average Exercise Price
 
Number Exercisable
 
Weighted-Average Remaining Contractual Term (Years)
 
Weighted-Average Exercise Price
$
3.00 to 4.50
 
452,188
 
9.49
 
$
3.00
 
45,647
 
9.43
 
$
3.02
$
4.50 to 7.50
 
560,062
 
8.85
 
$
5.66
 
105,343
 
6.11
 
$
5.20
$
7.50 to 11.25
 
11,313
 
4.03
 
$
7.90
 
11,258
 
4.01
 
$
7.88
$
191.22 to 262.43
 
5,414
 
6.09
 
$
221.91
 
5,414
 
6.09
 
$
221.91
   
1,028,977
 
9.06
 
$
5.66
 
167,662
 
6.87
 
$
11.78

As of June 30, 2011 and December 31, 2010, 167,662 and 129,631 outstanding options were exercisable at an aggregate average exercise price of $11.78 and $14.25, respectively.  The aggregate intrinsic value of stock options outstanding and stock options exercisable at June 30, 2011 was less than $0.1 million.

As of June 30, 2011, total compensation cost related to non-vested stock options not yet recognized was $2.5 million, of the $2.5 million, $0.9 million is expected to recognized over the next three years on a weighted average basis, and includes stock options with contingent vesting.  The remaining $1.6 million is related to stock options in Tranches 2, 3, and 4 with contingent vesting which will be recognized when it is probable the options will become exercisable.

Valuation and Expense Information

The Company measures and recognizes compensation expense for all share-based payment awards made to employees and directors based upon estimated fair values.  The following table summarizes stock-based compensation expense recorded for the six months ended June 30, 2011 and 2010, and its allocation within the Consolidated Statements of Operations:

   
June 30,
 
   
2011
   
2010
 
Selling and marketing
 
$
62,934
   
$
62,492
 
General and administrative
   
100,993
     
140,068
 
Research and development
   
86,518
     
88,602
 
Stock based compensation included in continuing operations
   
250,445
     
291,162
 
Stock based compensation in discontinued operations
   
-
     
143,498
 
Total stock-based compensation expense related to employee equity awards
 
$
250,445
   
$
434,660
 

Valuation Assumptions:

The Company uses the Black Scholes option pricing model in determining its option expense.  The weighted-average estimated fair value of employee stock options granted during the six months ended June 30, 2011 was $2.68 per share.  There were no options granted during the three months ended June 30, 2011.  There were no options granted during the three and six months ended June 30, 2010.  The fair value of each option is estimated on the date of grant using the Black Scholes option pricing model and is recognized as expense using the straight-line method over the requisite service period.

As the stock-based compensation expense recognized in the Consolidated Statements of Operations is based on awards ultimately expected to vest, such amounts have been reduced for estimated forfeitures estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.